tiprankstipranks

Ron Bentsur Insider Profile

11 Followers
Ron Bentsur, CEO, Director at Keryx Biopharma, holds 3.27M shares in Nuvectis Pharma (Ticker: NVCT), holds 144.74K shares in Beyond Air (Ticker: XAIR), holds 0.00 shares in Stemline Therapeutics (Ticker: STML). Most recently, Ron Bentsur Bought ― shares of Nuvectis Pharma on Nov 18, 2024 for an estimated value of 98.40K.
tipranks
Ron Bentsur

Ron Bentsur
Keryx Biopharma (KERX)
CEO, Director

Ranked #7,797 out of 99,797 Corporate Insiders

Profitable Transactions

52%
30 out of 58 Profitable Transactions

Average Return

+7.00%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$15M
99.41%
0.39%
0.19%
A breakdown of Ron Bentsur's holdings

Insider Roles

Nuvectis Pharma
(NVCT)
Chairman & CEO, Director, Ten Percent Owner
Beyond Air
(XAIR)
Director
XTL Biopharmaceuticals Ltd. Sponsored ADR
(XTLB)
CEO
Roles that Ron Bentsur holds in companies

Most Profitable Insider Trade

Stock:
Nuvectis Pharma
(NVCT)
Rating:Informative Buy
Date:Feb 11, 2022 - Feb 11, 2023
Return:+107.00%
The most profitable trade made by Ron Bentsur

Ron Bentsur's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
KERX
Keryx Biopharma
Apr 08, 2015
Informative Sell
18.59K
$2.61M
Beyond Air
Mar 21, 2023
Director
Informative Buy
14.90K
$58.33K
Nuvectis Pharma
Nov 18, 2024
Chairman & CEO, Director, Ten Percent Owner
Informative Buy
98.40K
$14.76M
STML
Stemline Therapeutics
Jun 10, 2020
Uninformative Sell
$0.00
XTL Biopharmaceuticals Ltd. Sponsored ADR
CEO
$28.95K
List of latest transactions for each holding click on a transaction to see Ron Bentsur's performance on stock

Ron Bentsur insider profile FAQ

What is the percentage of profitable transactions made by Ron Bentsur?
The percentage of profitable transactions made by Ron Bentsur is 52%.
    What is the average return per transaction made by Ron Bentsur?
    The average return per transaction made by Ron Bentsur is 7.00%.
      What stocks does Ron Bentsur hold?
      Ron Bentsur holds: KERX, XAIR, NVCT, STML, XTLB stocks.
        What was Ron Bentsur’s latest transaction?
        Ron Bentsur latest transaction was an Informative Buy of $98.40K.
          What was Ron Bentsur's most profitable transaction?
          Ron Bentsur’s most profitable transaction was an Informative Buy of NVCT stock on February 11, 2022. The return on the trade was 107.00%.
            What is Ron Bentsur's role in Keryx Biopharma?
            Ron Bentsur's role in Keryx Biopharma is CEO, Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.